Anhydroicaritin alleviates psoriasis inflammation and keratinocyte hyperproliferation via regulating JAK-STAT3 signaling pathway (PRJCA043316)
The findings imply that ANHcould serve as a potential therapeutic choice for the control of psoriasis.